2 recruiting, 2 terminated, 2 withdrawn, 1 enrolling by invitation. 3 Not applicable, 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Enrolling by invitation 1, Recruiting 1, Terminated 1 |
| Phase 2 | 2 | Recruiting 1, Terminated 1 |
| Phase 3 | 2 | Withdrawn 2 |
Follow Short Gut Syndrome: new trials by email Literature Review of Short Gut Syndrome trials Research Report on Short Gut Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC) Crofelemer Powder for Oral Solution, Matched Placebo Powder for Oral Solution - Short Bowel Syndrome, Malabsorption Syndromes | Phase 2 | Recruiting | Napo Therapeutics, S.p.A. | 18 | 2025-05-29 | 2026-06-09 |
| Successful Fiber Food Introduction in Short Bowel Syndrome Green bean puree - Short Gut Syndrome | Not applicable | Enrolling by invitation | University of Texas Southwestern Medical Center | 60 | 2024-04-19 | 2025-11-25 |
| Fiber Food Introduction in Pediatric Short Bowel Syndrome Green bean puree - Short Gut Syndrome | Not applicable | Recruiting | Children's Hospital of Philadelphia | 60 | 2022-05-08 | 2026-07-10 |
| Functional Sucrase Deficiency in Short Bowel Syndrome Patients With Intestinal Failure Sucrase, Placebo - Short Gut Syndrome | Phase 2 | Terminated | University of Miami | 3 | 2022-01-31 | 2025-10-01 |
| Innovative Central Line Securement Device in the Pediatric Population Wearable Central Line Securement Device (Vest), Traditional Securement Dressing - Central Line Complication, Central Line Infection | Not applicable | Terminated | Ryan St. Pierre-Hetz | 23 | 2020-11-05 | 2024-07-05 |
| A Open Label Extension Study for Subjects That Complete Study MP-101-CL-001 0.6 mL, MP-101 (10 mg/mL, Opium Tincture (OT)), USP (Deodorized) - Short Bowel Syndrome, Short Gut Syndrome | Phase 3 | Withdrawn | Marathon Pharmaceuticals, LLC | 2015-02-01 | 2015-02-18 | |
| A Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Investigational Product MP-101 in Subjects With Short Bowel Syndrome Who Have Had an Inadequate Response to Anti-Diarrheals Opium Tincture USP Deodorized - Short Bowel Syndrome, Short Gut Syndrome | Phase 3 | Withdrawn | Marathon Pharmaceuticals, LLC | 2014-12-01 | 2015-02-18 |
Short Bowel Syndrome (7) · Gastrointestinal Diseases (1) · Intestinal Failure (1) · MYH9-Related Disorders (1) · Malabsorption Syndromes (1) · Postoperative Complications (1)
Digestive System Diseases (7) · Intestinal Diseases (7) · Pathologic Processes (7) · Pathological Conditions, Signs and Symptoms (7) · Gastrointestinal Diseases (6) · Malabsorption Syndromes (6) · Postoperative Complications (6) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1)
Marathon Pharmaceuticals, LLC (2) · Children's Hospital of Philadelphia (1) · Napo Therapeutics, S.p.A. (1) · Ryan St. Pierre-Hetz (1) · University of Miami (1) · University of Texas Southwestern Medical Center (1)
United States (6) · Germany (1) · Italy (1)
Wenjing Zong, MD (2) · Amanda Fifi, MD (1) · Angelica Mazzarini, MD (1) · Christina Bales, MD (1) · Lindsey Albenberg, DO (1)